Elon Musk’s Neuralink Chip To Aid Paralysed People | Trials Begin In Great Britain
In July 2025, Neuralink—the ambitious brain-computer interface company founded by Elon Musk—took a major step toward making science fiction a reality. The company announced the launch of its first human clinical study in Great Britain, marking a milestone in its mission to restore independence to people living with severe paralysis.
The trial, officially named GB-PRIME (Great Britain – Precision Restoration of Independence via Mind-Enabled control), will evaluate whether Neuralink’s N1 “Link” implant can enable users to control computers, mobile devices, and even physical equipment using nothing but their thoughts.
What is the N1 “Link”?
Roughly the size of a coin, the N1 “Link” is a fully implantable brain-computer interface designed to detect and translate neural activity into digital commands. The device sits under the skull, with microscopic electrodes extending into targeted regions of the brain to read electrical signals from neurons.
In theory, this allows a person to move a cursor, type messages, operate smart home devices, or even control robotic limbs without any physical movement.
Musk has previously described the technology as “a Fitbit in your skull, but with tiny wires”—capable not only of aiding those with disabilities, but potentially upgrading human cognition in the future.
Who Will Participate?
The GB-PRIME trial will initially enroll a small group of volunteers with complete or near-complete paralysis due to spinal cord injuries or neurological disorders like ALS.
Each participant will undergo a surgical procedure to implant the N1 “Link” in a motor control region of the brain, followed by months of training with Neuralink’s software and rehabilitation specialists.
“Our focus right now is restoring independence,” said Dr. Sophie Kavanagh, Neuralink’s UK clinical lead. “We want our participants to be able to send an email, browse the web, or interact with loved ones online without relying on a caregiver to operate a device for them.”
Regulatory Green Light
Neuralink received ethics committee approval and UK regulatory clearance earlier this year, after months of safety reviews and technical audits. Officials emphasised that the trial will be closely monitored, with all data collected under strict privacy controls.
A Global Race in Brain Tech
The UK trial follows Neuralink’s earlier human implant surgeries in the United States under the PRIME Study, which began in 2024. Other companies, including Synchron and Blackrock Neurotech, are also developing similar brain-computer interfaces, but Neuralink’s approach—high-density electrodes with wireless data transmission—remains among the most ambitious.
Industry analysts say success in GB-PRIME could fast-track regulatory approval in Europe and pave the way for commercial availability within the next decade.
Elon Musk’s Vision
In a brief statement on X (formerly Twitter), Musk wrote:
“The ultimate goal is to give people their digital freedom back. If you can think it, you can do it.”
For now, Neuralink insists its mission is medical—but Musk has never hidden his belief that brain-computer interfaces could one day merge human intelligence with artificial intelligence.
What’s Next?
Initial results from GB-PRIME are expected in mid-2026. If the trial proves successful, Neuralink hopes to expand the technology to a wider patient base, potentially transforming the way millions of people with paralysis interact with the world.
“We’re at the beginning of something that could redefine what it means to live with a disability,” Dr. Kavanagh said. “The possibilities are as exciting as they are profound.”
